Heart failure trials in Czechia
44 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEndovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction
- Where
- Prague
- Age
- 40 years and over
- People
- 50 worldwide
- Run by
- Axon Therapies, Inc.
See details and how to joinNCT07403058 - No phaseTaking peopleTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Where
- Prague
- Age
- 18 years and over
- People
- 850 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT06526195 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Prague
- People
- 20,000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - No phaseTaking peopleELEVATE-HFpEF Clinical Study
- Where
- Prague
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
See details and how to joinNCT06678841 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Brandýs nad Labem, Brno, Broumov, Bruntál, Chlumec nad Cidlinou, Chomutov, Havirov - Mesto, Holešov, Hradec Králové, Jaroměř, Liberec, Mělník, Náchod, Olomouc, Ostrava, Pardubice, Prague, Praha 5 - Smichov, Přerov, Prostějov, Slaný, Trutnov, Uherské Hradiště, Ústí nad Labem
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Bílovec, Brandýs nad Labem, Brno, Brno-Stred, Brno-Zidenice, Chrudim IV, Havlickuv Brod, Horni Predmesti, Litovel, Mariánské Lázně, Prague, Prague 1, Prague 4, Pulecny, Smiřice, Uherské Hradiště, Zlín
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Bílovec, Brandýs nad Labem, Brno-Stred, Chrudim IV, Horni Predmesti, Jaroměř, Litovel, Louny, Mariánské Lázně, Nova Ulice, Prague, Prague 1, Slaný, Uherské Hradiště
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Brandýs nad Labem, Brno, Brno-Královo Pole, Brno-Stred, Brno-Zidenice, Broumov, Bruntal, Chlumec nad Cidlinou, Chomutov, Havířov, Holesov, Horni Brana, Horni Predmesti, Hradec Králové, Jaroměř, Liberec, Melnik, Moravska Ostrava A Privoz, Náchod, Olomouc, Ostrava, Pardubice, Pardubice I, Prague, Prague 1, Prague 2, Prerov I-Mesto, Prostějov, Slaný, Uherske Hradiste, Uherské Hradiště, Usti nad Labem, Ústí nad Labem, Valasske Mezirici
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Brno, Prague
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - Phase 2Taking peopleA Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Where
- Brno, Brno-Královo Pole, Hradec Králové, Jaroměř, Krnov, Ostrava, Prerov
- Age
- 18 years to 79 years
- People
- 620 worldwide
- Run by
- Pfizer
See details and how to joinNCT06991257 · EU 2024-518438-94-00 - No phaseTaking peopleBIO|STREAM.CSP Study
- Where
- Olomouc, Prague
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Biotronik SE & Co. KG
See details and how to joinNCT07393009 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Benešov, Brandýs nad Labem, Brno-Stred, Chlumec nad Cidlinou, Hodonin, Humpolec, Jaroměř, Jesenice, Krnov, Mariánské Lázně, Moravska Ostrava A Privoz, Olomouc, Plzeň 3, Police nad Metuji, Prague, Praha
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Brno, Broumov, Olomouc, Ostrava - Poruba, Prague, Uherské Hradiště
- Age
- 18 years and over
- People
- 1,280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Brno, Prague
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Brno, Broumov, Česká Lípa, Jaroměř, Louny, Ostrava, Pilsen, Plzen - Bory, Prague, Přerov, Slaný, Svitavy, Ustí Nad Labem, Zlín
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - Phase 3Taking peopleMulti-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- Where
- Brandýs nad Labem, Brno, Brno-Stred, Brno-Zidenice, Chlumec Nad Cidlinou Iv, Ostrava, Plzen 3, Prague, Uherské Hradiště, Znojmo
- Age
- 18 years and over
- People
- 1,900 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT06929806 · EU 2024-519059-28-00 - Phase 3Taking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Benešov, Boskovice, Brno-Stred, Broumov, Cesky Krumlov, Hradec Králové, Hustopece u Brna, Jaroměř, Klatovy IV, Liberec I-Stare Mesto, Louny, Prague, Teplice, Vsetin
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - Phase 4Taking peopleAcalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
- Where
- Brno, Hradec Králové, Prague
- Age
- 18 years to 130 years
- People
- 60 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06651970 - Phase 2/3Taking peopleRandomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
- Where
- Konska, Olomouc, Prague
- Age
- 18 years to 80 years
- People
- 600 worldwide
- Run by
- Seismic Pharmaceuticals Operations LLC
See details and how to joinNCT07583446 · EU 2026-527261-29-00 - Phase 1/2Taking peopleA Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care.
- Where
- Plzen 23, Prague
- Age
- 18 years to 80 years
- People
- 90 worldwide
- Run by
- 4TEEN4 Pharmaceuticals GmbH
See details and how to joinNCT06832722 · EU 2024-518450-16-00 - Phase 2Not yet taking people in CzechiaA Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
- Where
- Brandýs nad Labem, Brno, Broumov, Klatovy IV, Louny, Mlada Boleslav III, Pardubice I
- Age
- 18 years to 85 years
- People
- 400 worldwide
- Run by
- AnaCardio AB
See details and how to joinNCT07584967 · EU 2025-524469-25-00 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Brno, Chlumec nad Cidlinou, Pilsen, Prague, Roudnice nad Labem
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197 - No phaseEnrolling by invitationSnapshot Study on Patients With Heart Failure
- Where
- Brno, Broumov, České Budějovice, Havířov, Hradec Králové, Jaroměř, Motol, Náchod, Ostrava, Pardubice, Pilsen, Prague
- Age
- 18 years and over
- People
- 4,000 worldwide
- Run by
- European Society of Cardiology
See details and how to joinNCT06469814 - Phase 2Not yet taking people in CzechiaA Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFREF) (CALIBRATE-HF)
- Where
- Brno-Stred, Hradec Králové, Jaroměř, Louny, Pardubice I, Prague, Prague 2
- Age
- 18 years and over
- People
- 369 worldwide
- Run by
- Cardurion Pharmaceuticals Inc.
See details and how to join2025-525033-31-00 · EU 2025-525033-31-00 - No phaseTaking peopleA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Olomouc, Prague
- Age
- 18 years and over
- People
- 1,700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705